» Articles » PMID: 17854349

Neuroprotective Actions of Noradrenaline: Effects on Glutathione Synthesis and Activation of Peroxisome Proliferator Activated Receptor Delta

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2007 Sep 15
PMID 17854349
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Abeta) 1-42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Abeta-dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Abeta did not induce nitrite production from neurons, LDH release was not reduced by co-incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co-incubation with NA partially reduced Abeta-induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of gamma-glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co-treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARdelta) agonist. NA also increased expression and activation of PPARdelta. Together these data demonstrate that NA can protect neurons from Abeta-induced damage, and suggest that its actions may involve activation of PPARdelta and increases in GSH production.

Citing Articles

Neuroprotective actions of norepinephrine in neurological diseases.

Ghasemi M, Mehranfard N Pflugers Arch. 2024; 476(11):1703-1725.

PMID: 39136758 DOI: 10.1007/s00424-024-02999-w.


MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders: Engineered extracellular vesiclesand retinal ischemia.

Mathew B, Acha L, Torres L, Huang C, Liu A, Kalinin S Acta Biomater. 2023; 158:782-797.

PMID: 36638942 PMC: 10005109. DOI: 10.1016/j.actbio.2023.01.014.


Selective Vulnerability of the Locus Coeruleus Noradrenergic System and its Role in Modulation of Neuroinflammation, Cognition, and Neurodegeneration.

Evans A, Defensor E, Shamloo M Front Pharmacol. 2022; 13:1030609.

PMID: 36532725 PMC: 9748190. DOI: 10.3389/fphar.2022.1030609.


White matter alterations in heart-kidney imbalance insomnia and Jiao-Tai-Wan treatment: A diffusion-tensor imaging study.

Chen J, Li Y, Xia N, Wen C, Xia T, Zhuang Y Brain Imaging Behav. 2022; 16(4):1803-1812.

PMID: 35338430 PMC: 9279240. DOI: 10.1007/s11682-022-00653-6.


Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration.

Durai P, Beeraka N, Ramachandrappa H, Krishnan P, Gudur P, Raghavendra N Curr Neuropharmacol. 2021; 20(5):893-915.

PMID: 34751120 PMC: 9881103. DOI: 10.2174/1570159X19666211109141330.